COSMOBIO

Cosmo Bio is a prominent Japanese provider of life science research reagents, instruments, and clinical diagnostic tools. Established in 1983 and headquartered in Tokyo, the company serves as a major distributor for over 600 international suppliers, facilitating the entry of global biotech products into the Japanese market. Beyond distribution, Cosmo Bio operates its own manufacturing and R&D facilities to develop proprietary products, including specialized antibodies, ELISA kits, and cell culture reagents. The company is publicly traded on the Tokyo Stock Exchange and maintains a significant international presence through its US-based subsidiary, Cosmo Bio USA. Its comprehensive portfolio supports a wide range of research areas, including oncology, immunology, and regenerative medicine.